AstraZeneca

Italy influenza, COVID-19 and RSV vaccination rollout

22 clusters · 202 sources · last updated about 2 hours ago

Latest: Italy launches regional vaccination campaigns in Marche and Molise

The 2026-2027 seasonal vaccination campaign in Italy, targeting influenza, COVID-19, and Respiratory Syncytial Virus (RSV), is underway following preparations in September. Ahead of the October rollout, the Italian Medic

Brazil cancer burden, screening, treatment & legislation

34 clusters · 227 sources · last updated about 10 hours ago

Latest: Brazil's SUS reports increase in breast reconstruction surgeries

Brazil is advancing legislative and policy measures to address its rising cancer burden. The Senate's Social Affairs Commission (CAS) is reviewing a project to improve the National Cancer Patient Navigation Program to op

ES-SCLC combination therapy clinical trial results

2 clusters · 20 sources · last updated about 12 hours ago

Latest: New lung cancer therapy reduces death risk by 58%

Results from the Phase 3 DeLLphi-305 clinical trial indicate that a combination of Amgen’s Imdelltra (tarlatamab) and AstraZeneca’s Imfinzi (durvalumab) significantly improves survival outcomes for patients with extensiv

Lunit medical AI oncology research collaborations

2 clusters · 5 sources · last updated about 20 hours ago

Latest: Lunit partners with Summit Therapeutics for AI biomarker research

Medical AI company Lunit has announced several research initiatives to advance cancer treatment. At the ESMO 2026 Congress, the company will present findings from its ‘AI forHER’ project, a collaboration with AstraZeneca

NVIDIA leadership engagement in global AI development

6 clusters · 42 sources · last updated 1 day ago

Latest: Nvidia CEO projects revenue growth through next-gen chips and AI software

NVIDIA CEO Jensen Huang has engaged in high-level international activities focused on the expansion and regulation of artificial intelligence. In September 2026, Huang scheduled his first visit to Kazakhstan to participa

AI integration in life sciences and clinical practice

2 clusters · 24 sources · last updated 6 days ago

Latest: OpenAI acquires biotech startup Orchestra Bio

The life sciences and healthcare sectors are increasingly integrating artificial intelligence to optimize drug development and clinical workflows. Oracle and AstraZeneca have entered a non-binding agreement to utilize A

International summits in the United Arab Emirates

3 clusters · 10 sources · last updated 8 days ago

Latest: Dubai AI Festival 2026 to convene global technology leaders

The United Arab Emirates is hosting several high-level international summits in October 2026 focused on health, leadership, and economic investment. In Abu Dhabi, the Future Health Summit is scheduled for October 20–22.

Cancer treatment and diagnosis in Central America

2 clusters · 7 sources · last updated 9 days ago

Latest: Central America faces cancer treatment and diagnosis challenges

Central American nations, including Costa Rica, Guatemala, El Salvador, Honduras, Nicaragua, and Panama, face significant public health challenges regarding cancer, characterized by late-stage diagnoses and limited acces

Preparations for 9th China International Import Expo

4 clusters · 8 sources · last updated 11 days ago

Latest: China International Import Expo to be held in Shanghai this November

Preparations for the 9th China International Import Expo (CIIE), scheduled for November 5 to 10 at the National Exhibition and Convention Center in Shanghai, have reached new milestones. The event is expected to host 162

AI supercomputer infrastructure development in Sweden

2 clusters · 12 sources · last updated 11 days ago

Latest: Sferical One AI supercomputer launches in Sweden

The deployment of high-performance AI supercomputing infrastructure in Sweden has progressed through two distinct initiatives. Initially, Scaleway, a subsidiary of the French group Iliad, announced plans to install its

AstraZeneca R&D and AI drug discovery expansion

2 clusters · 6 sources · last updated 11 days ago

Latest: AstraZeneca partners with insitro in $1.5B AI drug discovery deal

AstraZeneca has expanded its research and development capabilities through significant infrastructure investment and strategic partnerships focused on artificial intelligence. In mid-October 2026, the company opened a n

Multiple myeloma treatment regulatory approvals

2 clusters · 16 sources · last updated 12 days ago

Latest: AIFA approves belantamab mafodotin for multiple myeloma in Italy

Regulatory authorities have granted approvals for new multiple myeloma treatments in the United States and Italy. In September 2026, the US Food and Drug Administration (FDA) issued accelerated approval for iberdomide.

Global cancer awareness expands amid French and Senegalese

16 clusters · 88 sources · last updated 13 days ago

Latest: Morel supports breast cancer awareness through Pink October campaign

Cancer awareness and support initiatives continue to expand across Canada, France, North Africa, and the Caribbean. In Canada, the Canadian Cancer Society’s CIBC Race for Life is preparing for its 35th edition in Quebec.

Advancements in cancer diagnosis and treatment

2 clusters · 19 sources · last updated 14 days ago

Latest: Liver cancer treatment: New immunotherapy shows 17% 6-year survival rate

Medical technology continues to advance in the diagnosis and treatment of various cancers. Developments include Contrast Enhanced Mammography, which uses iodine-based dye to identify cancers in dense breast tissue more e

CPHI Milan 2026 pharmaceutical conference

4 clusters · 12 sources · last updated 18 days ago

Latest: Greek pharmaceutical industry showcases growth at CPHI Milan

The CPHI Milan 2026 conference, held at Fiera Milano from October 6 to 8, serves as a major international gathering for the pharmaceutical and biotech industries. The event is expected to host over 62,000 visitors and 2,

Barriers to rare cancer treatment and research

2 clusters · 4 sources · last updated 18 days ago

Latest: Medical experts highlight gaps in rare tumor and adolescent cancer care

Medical experts and advocacy groups are identifying systemic barriers to treatment and research for rare cancers and vulnerable patient populations. In the United States, insurance coverage gaps have been highlighted by

Global medical trends in oncology and chronic care

2 clusters · 16 sources · last updated 18 days ago

Latest: Medical experts highlight advancements in COPD and integrative oncology

Medical discussions are increasingly focusing on holistic approaches to chronic disease and cancer management, with a central emphasis on patient quality of life. In the field of oncology, initiatives such as the ‘Vivir

Cofepris pharmaceutical and sanitary alerts in Mexico

4 clusters · 22 sources · last updated 21 days ago

Latest: Cofepris issues alert for counterfeit ADerogyl, Darzalex, and Simponi medications

Mexico’s Federal Commission for Protection against Sanitary Risks (Cofepris) has expanded its health alerts regarding counterfeit, adulterated, and stolen medical products. Following initial warnings about counterfeit C

AstraZeneca investment in Summit Therapeutics

2 clusters · 19 sources · last updated 22 days ago

Latest: AstraZeneca invests $2 billion in Summit Therapeutics for cancer drug trials

AstraZeneca has initiated a $2 billion strategic equity investment in Summit Therapeutics through the purchase of convertible preferred stock. This deal is intended to accelerate the development of the investigational PD

AstraZeneca regulatory and portfolio developments

3 clusters · 5 sources · last updated 26 days ago

Latest: AstraZeneca and Johnson & Johnson advance new cancer treatments

AstraZeneca has achieved several regulatory milestones regarding its oncology and rare disease pipelines. In Europe, the company received approval for Enhertu in combination with pertuzumab for first-line treatment of HE

FDA priority reviews for new medical therapies

2 clusters · 5 sources · last updated 27 days ago

Latest: Roche's fenebrutinib receives FDA priority review for multiple sclerosis

The U.S. Food and Drug Administration (FDA) has granted priority review to several new investigational therapies for various medical conditions. In late September 2026, the FDA granted priority review to Bayer’s elinzan

South Korean rare disease insurance reform advocacy

2 clusters · 3 sources · last updated 27 days ago

Latest: South Korean rare disease patients urge health insurance reform

Patient advocacy groups and industry representatives in South Korea are campaigning for reforms to the national health insurance reimbursement system to improve access to treatments for rare and severe diseases. Initial

China biopharmaceutical industry growth

4 clusters · 26 sources · last updated 29 days ago

Latest: China shifts pharmaceutical industry toward high-quality innovation and wellness

China is expanding its national health insurance coverage to include more innovative drugs, specifically targeting cancer, chronic, rare, and pediatric conditions. Since 2018, the National Healthcare Security Administrat